Literature DB >> 2842787

The CGTCA sequence motif is essential for biological activity of the vasoactive intestinal peptide gene cAMP-regulated enhancer.

J S Fink1, M Verhave, S Kasper, T Tsukada, G Mandel, R H Goodman.   

Abstract

cAMP-regulated transcription of the human vasoactive intestinal peptide gene is dependent upon a 17-base-pair DNA element located 70 base pairs upstream from the transcriptional initiation site. This element is similar to sequences in other genes known to be regulated by cAMP and to sequences in several viral enhancers. We have demonstrated that the vasoactive intestinal peptide regulatory element is an enhancer that depends upon the integrity of two CGTCA sequence motifs for biological activity. Mutations in either of the CGTCA motifs diminish the ability of the element to respond to cAMP. Enhancers containing the CGTCA motif from the somatostatin and adenovirus genes compete for binding of nuclear proteins from C6 glioma and PC12 cells to the vasoactive intestinal peptide enhancer, suggesting that CGTCA-containing enhancers interact with similar transacting factors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2842787      PMCID: PMC282037          DOI: 10.1073/pnas.85.18.6662

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Tissue-specific enhancer of the human glycoprotein hormone alpha-subunit gene: dependence on cyclic AMP-inducible elements.

Authors:  A M Delegeane; L H Ferland; P L Mellon
Journal:  Mol Cell Biol       Date:  1987-11       Impact factor: 4.272

2.  Spatial relationship of the Fis binding sites for Hin recombinational enhancer activity.

Authors:  R C Johnson; A C Glasgow; M I Simon
Journal:  Nature       Date:  1987 Oct 1-7       Impact factor: 49.962

3.  The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection.

Authors:  C M Gorman; G T Merlino; M C Willingham; I Pastan; B H Howard
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

4.  Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements.

Authors:  W Lee; P Mitchell; R Tjian
Journal:  Cell       Date:  1987-06-19       Impact factor: 41.582

5.  Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene.

Authors:  M R Montminy; L M Bilezikjian
Journal:  Nature       Date:  1987 Jul 9-15       Impact factor: 49.962

6.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

7.  Cyclic AMP regulation of the human glycoprotein hormone alpha-subunit gene is mediated by an 18-base-pair element.

Authors:  B J Silver; J A Bokar; J B Virgin; E A Vallen; A Milsted; J H Nilson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

8.  A cellular transcription factor E4F1 interacts with an E1a-inducible enhancer and mediates constitutive enhancer function in vitro.

Authors:  K A Lee; M R Green
Journal:  EMBO J       Date:  1987-05       Impact factor: 11.598

9.  GCN4, a eukaryotic transcriptional activator protein, binds as a dimer to target DNA.

Authors:  I A Hope; K Struhl
Journal:  EMBO J       Date:  1987-09       Impact factor: 11.598

10.  The estrogen-responsive element as an inducible enhancer: DNA sequence requirements and conversion to a glucocorticoid-responsive element.

Authors:  E Martinez; F Givel; W Wahli
Journal:  EMBO J       Date:  1987-12-01       Impact factor: 11.598

View more
  48 in total

1.  Sequences and factors required for the F9 embryonal carcinoma stem cell E1a-like activity.

Authors:  E J Murray; D Stott; P W Rigby
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

2.  Induction of a cyclic AMP-responsive gene in living cells requires the nuclear factor CREB.

Authors:  J L Meinkoth; M R Montminy; J S Fink; J R Feramisco
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

3.  Molecular cloning of the human UMP synthase gene and characterization of point mutations in two hereditary orotic aciduria families.

Authors:  M Suchi; H Mizuno; Y Kawai; T Tsuboi; S Sumi; K Okajima; M E Hodgson; H Ogawa; Y Wada
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

Review 4.  Neuropeptide gene expression and neural activity: assessing a working hypothesis in nucleus caudalis and dorsal horn neurons expressing preproenkephalin and preprodynorphin.

Authors:  G R Uhl; T Nishimori
Journal:  Cell Mol Neurobiol       Date:  1990-03       Impact factor: 5.046

Review 5.  Molecular mechanisms of cAMP-regulated gene expression.

Authors:  K M Walton; R P Rehfuss
Journal:  Mol Neurobiol       Date:  1990 Fall-Winter       Impact factor: 5.590

6.  Expression patterns and promoter characteristics of the Vitis quinquangularis VqSTS36 gene involved in abiotic and biotic stress response.

Authors:  Xiangjing Yin; Li Huang; Xiuming Zhang; Chunlei Guo; Hao Wang; Zhi Li; Xiping Wang
Journal:  Protoplasma       Date:  2017-05-04       Impact factor: 3.356

7.  Multiple sequence elements of a single functional class are required for cyclic AMP responsiveness of the mouse c-fos promoter.

Authors:  L A Berkowitz; K T Riabowol; M Z Gilman
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

8.  Distinguishable promoter elements are involved in transcriptional activation by E1a and cyclic AMP.

Authors:  K A Lee; J S Fink; R H Goodman; M R Green
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

9.  Molecular structure of the human muscle-specific enolase gene (ENO3).

Authors:  M Peshavaria; I N Day
Journal:  Biochem J       Date:  1991-04-15       Impact factor: 3.857

Review 10.  Transcriptional regulation by cAMP and Ca2+ links the Na+/Ca2+ exchanger 3 to memory and sensory pathways.

Authors:  Nadia Gabellini
Journal:  Mol Neurobiol       Date:  2004-08       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.